Singapore markets closed

Teladoc Health, Inc. (TDOC)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
34.35-0.73 (-2.08%)
At close: 04:00PM EDT
33.40 -0.95 (-2.77%)
Pre-market: 06:48AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.04B
Enterprise value 6.78B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)2.78
Price/book (mrq)0.66
Enterprise value/revenue 3.16
Enterprise value/EBITDA -1.02

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 3-79.14%
S&P500 52-week change 3-11.60%
52-week high 3167.50
52-week low 327.38
50-day moving average 336.97
200-day moving average 382.34

Share statistics

Avg vol (3-month) 38.07M
Avg vol (10-day) 35.81M
Shares outstanding 5161.18M
Implied shares outstanding 6N/A
Float 8159.3M
% held by insiders 11.36%
% held by institutions 184.05%
Shares short (14 Jun 2022) 436.65M
Short ratio (14 Jun 2022) 46.64
Short % of float (14 Jun 2022) 425.93%
Short % of shares outstanding (14 Jun 2022) 422.74%
Shares short (prior month 12 May 2022) 438.2M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-10.52%

Management effectiveness

Return on assets (ttm)-0.98%
Return on equity (ttm)-55.29%

Income statement

Revenue (ttm)2.14B
Revenue per share (ttm)13.48
Quarterly revenue growth (yoy)24.60%
Gross profit (ttm)1.38B
EBITDA -7.71M
Net income avi to common (ttm)-6.9B
Diluted EPS (ttm)-43.42
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)838.99M
Total cash per share (mrq)5.2
Total debt (mrq)1.61B
Total debt/equity (mrq)17.58
Current ratio (mrq)3.94
Book value per share (mrq)56.63

Cash flow statement

Operating cash flow (ttm)180.27M
Levered free cash flow (ttm)231.45M